Literature DB >> 16283325

Oxalate and its handling in a low stone risk vs a stone-prone population group.

Sonja Lewandowski1, Allen L Rodgers, Norbert Laube, Gerd von Unruh, Diana Zimmermann, Albrecht Hesse.   

Abstract

Despite hyperoxalurogenic eating habits relative to white subjects, South African blacks have urinary oxalate excretions, Tiselius risk indices (AP(CaOx)) and calcium oxalate saturations, which do not differ significantly from those of their white counterparts. The present study was undertaken to establish whether the BONN-Risk-Index (BRI) might discriminate between the urines of the two population groups and whether differences might exist in their respective gastrointestinal absorption rates of oxalate. Participants (n = 15 in each group) provided 24 h urines on their free diets for BRI determination. Gastrointestinal oxalate absorption was measured using the [13C2]oxalate absorption test. Results showed that BRI values were significantly lower in black subjects (2.04 vs 4.90, P = 0.034), but that there was no difference in the oxalate absorption between the groups (10.30 vs 9.95%, P = 0.87). These results suggest that South African black subjects handle dietary oxalate more efficaciously than white subjects and that this occurs via some endogenous mechanism, which has not yet been identified or characterized.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283325     DOI: 10.1007/s00345-005-0030-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  17 in total

1.  EQUIL2: a BASIC computer program for the calculation of urinary saturation.

Authors:  P G Werness; C M Brown; L H Smith; B Finlayson
Journal:  J Urol       Date:  1985-12       Impact factor: 7.450

2.  The aetiology of renal stone: a new concept arising from studies on a stone-free population.

Authors:  M Modlin
Journal:  Ann R Coll Surg Engl       Date:  1967-03       Impact factor: 1.891

3.  Risk factors in calcium stone disease of the urinary tract.

Authors:  W G Robertson; M Peacock; P J Heyburn; D H Marshall; P B Clark
Journal:  Br J Urol       Date:  1978-12

4.  The influence of a high-oxalate/low-calcium diet on calcium oxalate renal stone risk factors in non-stone-forming black and white South African subjects.

Authors:  S Lewandowski; A Rodgers; I Schloss
Journal:  BJU Int       Date:  2001-03       Impact factor: 5.588

5.  Mass spectrometric-selected ion monitoring assay for an oxalate absorption test applying [13C2]oxalate.

Authors:  G E von Unruh; M A Langer; D W Paar; A Hesse
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-09-25

Review 6.  Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment.

Authors:  Sonja Lewandowski; Allen L Rodgers
Journal:  Clin Chim Acta       Date:  2004-07       Impact factor: 3.786

7.  Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.

Authors:  Norbert Laube; Stefan Hergarten; Bernd Hoppe; Matthias Schmidt; Albrecht Hesse
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

8.  Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test.

Authors:  Gerd E von Unruh; Susanne Voss; Tilman Sauerbruch; Albrecht Hesse
Journal:  J Urol       Date:  2003-02       Impact factor: 7.450

9.  An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease.

Authors:  H G Tiselius
Journal:  Clin Chim Acta       Date:  1982-07-15       Impact factor: 3.786

10.  Effects of magnesium on calcium oxalate crystallization.

Authors:  M K Li; N J Blacklock; J Garside
Journal:  J Urol       Date:  1985-01       Impact factor: 7.450

View more
  11 in total

1.  Effects of vitamin E ingestion on plasma and urinary risk factors for calcium oxalate urolithiasis in two population groups having different stone-risk profiles: evidence of different physiological handling mechanisms.

Authors:  Takalani Theka; Allen Rodgers; Sonja Lewandowski; Dawn Webber; Shameez Allie-Hamdulay
Journal:  Urol Res       Date:  2011-12-03

2.  Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria.

Authors:  Klara Klimesova; Jonathan M Whittamore; Marguerite Hatch
Journal:  Urolithiasis       Date:  2014-10-01       Impact factor: 3.436

3.  Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles.

Authors:  Takalani Theka; Allen Rodgers; Neil Ravenscroft; Sonja Lewandowski
Journal:  Urolithiasis       Date:  2013-01-22       Impact factor: 3.436

Review 4.  Race, ethnicity and urolithiasis: a critical review.

Authors:  Allen L Rodgers
Journal:  Urolithiasis       Date:  2013-01-06       Impact factor: 3.436

5.  Spontaneous urinary calcium oxalate crystallization in hypercalciuric children.

Authors:  Tadeusz Porowski; Jerzy Konstantynowicz; Walentyna Zoch-Zwierz; Jan Krzysztof Kirejczyk; Katarzyna Taranta-Janusz; Agata Korzeniecka-Kozerska
Journal:  Pediatr Nephrol       Date:  2009-04-07       Impact factor: 3.714

6.  A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.

Authors:  Tadeusz Porowski; Walentyna Zoch-Zwierz; Jerzy Konstantynowicz; Katarzyna Taranta-Janusz
Journal:  Pediatr Nephrol       Date:  2008-03-12       Impact factor: 3.714

7.  Relevance of the BONN Risk Index for metabolic monitoring of patients with calcium oxalate urolithiasis: a clinical application study of the Urolizer.

Authors:  Wolfgang Berg; Robin Bechler; Claudia Haas; Norbert Laube
Journal:  Urol Res       Date:  2009-02-10

8.  Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.

Authors:  Tadeusz Porowski; Walentyna Zoch-Zwierz; Anna Wasilewska; Anthony Spotyk; Jerzy Konstantynowicz
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

9.  LITHORISK.COM: the novel version of a software for calculating and visualizing the risk of renal stone.

Authors:  Martino Marangella; Michele Petrarulo; Corrado Vitale; Piergiuseppe Daniele; Silvio Sammartano
Journal:  Urolithiasis       Date:  2020-11-27       Impact factor: 3.436

10.  Development of End Stage Renal Disease after Long-Term Ingestion of Chaga Mushroom: Case Report and Review of Literature.

Authors:  Sua Lee; Hwa Young Lee; Yohan Park; Eun Jeong Ko; Tae Hyun Ban; Byung Ha Chung; Hyun Soon Lee; Chul Woo Yang
Journal:  J Korean Med Sci       Date:  2020-05-18       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.